Bo Liu

Bo Liu is a highly accomplished individual with a diverse educational background and extensive professional experience in the fields of pharmacology, finance, and healthcare investments.

Bo Liu holds a Doctor of Philosophy in Pharmacology from the University of Rochester and the University of Rochester School of Medicine and Dentistry. Additionally, he earned a Master of Business Administration in Finance from The University of Chicago Booth School of Business, as well as a Master of Science in Medicine from Tongji Medical College of Hust.

In terms of professional roles, Bo Liu currently serves as the Executive Vice President and Managing Director of Healthcare Investments at Cdib Capital Group. Prior to this, he held key positions at renowned organizations such as Johnson & Johnson, GSK, and Charles River Laboratories. Bo Liu has served as the Principal of Venture Investments at JJDC, the Director of BD and Strategy in Consumer Healthcare China at GSK, and the Senior Associate of Corporate Development and Strategy at Charles River Laboratories.

Bo Liu's expertise spans across healthcare investments, venture capital, corporate development, and business strategy. His educational background in pharmacology and medicine, coupled with his business acumen gained through the MBA in Finance, has equipped him with a unique skill set to thrive in the competitive landscape of healthcare and finance.

Bo Liu's track record of success in various high-profile roles underscores his strategic thinking, leadership abilities, and deep understanding of the healthcare industry. His contributions to the field have been substantial, making him a respected figure in the domains of healthcare investments and corporate strategy.

Overall, Bo Liu's combination of academic achievements and professional accomplishments position him as a seasoned expert in pharmacology, finance, and healthcare investments, capable of driving innovation and growth in dynamic environments.